By Finance Pulse in IPO —

Maze Therapeutics Turns Profitable in 2024

Maze Therapeutics reports a profit for the first nine months of 2024, marking a turnaround from last year's losses. Discover the key factors driving this financial shift.

A sleek and modern graph with rising bars symbolizing financial growth, set against a backdrop of a
Maze Therapeutics Turns Profitable in 2024

Maze Therapeutics' IPO filing shows a profit for the first nine months of 2024, contrasting with a loss in the previous year.

Source